Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage;Mecanismos de degeneración secundaria en el sistema nervioso central durante los trastornos neuronales agudos y el daño en la sustancia blanca

Revista de Neurologia

Volumn 48, Issue 6, 2009, Pages 304-310

  Guimaraes J S ^a   Freire, M A M ^a   Lima, R R ^b   Souza Rodrigues, R D ^b   Costa, A M R ^b   Santos, C D Dos ^b   Picanco Diniz C W ^b   Gomes Leal, W ^b,c  

^a Instituto International de Neuro ciencia Edmon y Lily Safra de Natal IINN ELS   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c Instituto de Ciencias Biologicas   (Brazil)

Author keywords

Acute cerebral damage; Excitotoxicity; Inflammation; Neurodegeneration; Neuroprotection; White matter

Indexed keywords

GLUTAMIC ACID;

ANATOMY AND HISTOLOGY; CENTRAL NERVOUS SYSTEM; COMPLICATION; HUMAN; INFLAMMATION; METABOLISM; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY;

CENTRAL NERVOUS SYSTEM; GLUTAMIC ACID; HUMANS; INFLAMMATION; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 65149103452     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4806.2008512     Document Type: Review

References (83)

1. Gomes-Leal W, Corkill DJ, Freire MAM, Picanco-Diniz CW, Perry VH. Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp Neurol 2004; 190: 456-67.
2. Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002; 25: 532-7.
3. Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003; 126: 515-30.
4. Kraus JF, Black MA, Hessol N, Ley P, Rokaw W, Sullivan C, et al. The incidence of acute brain injury and serious impairment in a defined population. Am J Epidemiol 1984; 119: 186-201.
5. Kraus JF, Hooten EG, Brown KA, Peek-Asa C, Heye C, cArthur DL. Child pedestrian and bicyclist injuries: results of community surveillance and a case-control study. Inj Prev 1996; 2: 212-8.
6. Graham DI, Adams JH, Nicoll JA, Maxwell WL, Gennarelli TA. The nature, distribution and causes of traumatic brain injury. Brain Pathol 1995; 5: 397-406.
7. Kong LB, Lekawa M, Navarro RA, McGrath J, Cohen M, Margulies DR, et al. Pedestrian-motor vehicle trauma: an analysis of injury profiles by age. J Am Coll Surg 1996; 182: 17-23.
8. Kraus JF, Conroy C. Mortality and morbidity from injuries in sports and recreation. Annu Rev Public Health 1984; 5: 163-92.
9. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet 2002; 359: 417-25.
10. Petty MA, Wettstein JG. Elements of cerebral microvascular ischaemia. Brain Res Rev 2001; 36: 23-34.
11. Campos-Romo A. Evaluación de alteraciones motoras en modelos ani-males de enfermedad de Parkinson. Rev Neurol 2008; 46: 167-74.
12. Choi D. Antagonizing excitotoxicity: a therapeutic strategy for stroke? Mt Sinai J Med 1998; 65: 133-8.
13. Dewar D, Yam P, McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol 1999; 375: 41-50.
14. Yamaura I, Yone K, Nakahara S, Nagamine T, Baba H, Uchida K, et al. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine 2002; 27: 21-6.
15. Sánchez-Gómez MV, Matute C. Activation of AMPA and kainate glu-tamate receptors impairs the viability of oligodendrocytes in vitro. Int J Dev Biol 1996; Suppl 1: S187-8.
16. Gomes-Leal W, Corkill DJ, Picanco-Diniz CW. Systematic analysis of axonal damage and inflammatory response in different white matter tracts of acutely injured rat spinal cord. Brain Res 2005; 1066: 57-70.
17. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61: 657-68.
18. Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-76.
19. Choi DW. Glutamate receptors and the induction of excitotoxic neu-ronal death. Prog Brain Res 1994; 100: 47-51.
20. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438: 1162-6.
21. Somogyi P, Tamas G, Lujan R, Buhl EH. Salient features of synaptic organisation in the cerebral cortex. Brain Res Rev 1998; 26: 113-35.
22. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1-105.
23. Medina-Ceja L, Guerrero-Cazares H, Canales-Aguirre A, Morales-Vi-llagrán A, Feria-Velasco A. Caracteristicas estructurales y funcionales de los transportadores de glutamato: su relación con la epilepsia y el estrés oxidativo. Rev Neurol 2007; 45: 341-52.
24. Aschner M, Yao CP, Allen JW, Tan KH. Methylmercury alters gluta-mate transport in astrocytes. Neurochem Int 2000; 37: 199-206.
25. Olney JW. Excitotoxicity: an overview. Can Dis Wkly Rep 1990; 16 (Suppl 1E): 47-58.
26. Dusart I, Marty S, Peschanski M. Glial changes following an excito-toxic lesion in the CNS -II. Astrocytes. Neuroscience 1991; 45: 541-9.
27. Matute C, Alberdi E, Domercq M, Sanchez-Gomez MV, Perez-Samar-tin A, Rodriguez-Antiguedad A, et al. Excitotoxic damage to white matter. J Anat 2007; 210: 693-702.
28. Arundine M, Chopra GK, Wrong A, Lei S, Aarts MM, MacDonald JF, et al. Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro. J Neurotrauma 2003; 20: 1377-95.
29. Li XG, Florence SL, Kaas JH. Areal distributions of cortical neurons projecting to different levels of the caudal brain stem and spinal cord inrats. Somatosens Mot Res 1990; 7: 315-35.
30. Lynch DR, Dawson TM. Secondary mechanisms in neuronal trauma. Curr Opin Neurol 1994; 7: 510-6.
31. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 2002; 1: 383-6.
32. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med 2008; 14: 497-500.
33. Besancon E, Guo S, Lok J, Tymianski M, Lo EH. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008; 29: 268-75.
34. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neu-rotrauma 2000; 17: 871-90.
35. Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007; 82: 297-325.
36. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-29.
37. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 1991; 88: 6368-71.
38. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999; 9: 119-31.
39. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57-69.
40. Qin L, Block ML, Liu Y, Bienstock RJ, Pei Z, Zhang W, et al. Micro-glial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J 2005; 19: 550-7.
41. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 2003; 100: 6145-50.
42. Zekry D, Epperson TK, Krause KH. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 2003; 55: 307-13.
43. Buki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000; 20: 2825-34.
44. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 2001; 497: 1-5.
45. Adrain C, Creagh EM, Martin SJ. Apoptosis-associated release of Smac/Diablo from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 2001; 20: 6627-36.
46. Amin AR. A need for a 'whole-istic functional genomics' approach in complex human diseases: arthritis. Arthritis Res Ther 2003; 5: 76-9.
47. Allan SM, Rothwell NJ. Cytokines and acute eurodegeneration. Nat Rev Neurosci 2001; 2: 734-44.
48. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 2003; 358: 1669-77.
49. Perry VH, Bell MD, Brown HC, Matyszak MK. Inflammation in the nervous system. Curr Opin Neurobiol 1995; 5: 636-41.
50. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci 1999; 11: 3648-58.
51. Bell MD, Perry VH. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J Neurocytol 1995; 24: 695-710.
52. Zhang Z, Krebs CJ, Guth L. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response. Exp Neurol 1997; 143: 141-52.
53. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-7.
54. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 1999; 30: 77-105.
55. Streit WJ. Microglial response to brain injury: a brief synopsis. Toxicol Pathol 2000; 28: 28-30.
56. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002; 40: 133-9.
57. Minghetti L, Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 1998; 54: 99-125.
58. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW. Interleukin-1be- ta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 2003; 53: 588-95.
59. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 1999; 19: 1708-16.
60. Batchelor PE, Porritt MJ, Martinello P, Parish CL, Liberatore GT, Don- nan GA, et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci 2002; 21: 436-53.
61. Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 2001; 14: 810-20.
62. Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 2003; 24: 13-7.
63. Kim YS, Joh TH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 2006; 38: 333-47.
64. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 1993; 160: 139-44.
65. Blight AR, Decrescito V. Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. Neuroscience 1986; 19: 321-41.
66. Faden AI, Simon RP. A potential role for excitotoxins in the patho-physiology of spinal cord injury. Ann Neurol 1988; 23: 623-6.
67. Kanellopoulos GK, Xu XM, Hsu CY, Lu X, Sundt TM, Kouchoukos NT. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 2000; 31: 1945-52.
68. Irving EA, McCulloch J, Dewar D. Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Acta Neuropathol 1996; 92: 186-96.
69. Irving EA, Nicoll J, Graham DI, Dewar D. Increased tau immunoreac-tivity in oligodendrocytes following human stroke and head injury. Neurosci Lett 1996; 213: 189-92.
70. Irving EA, Yatsushiro K, McCulloch J, Dewar D. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J Cereb Blood Flow Metab 1997; 17: 612-22.
71. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000; 20: 1190-8.
72. Sadowsky C, Volshteyn O, Schultz L, McDonald JW. Spinal cord injury. Disabil Rehabil 2002; 24: 680-7.
73. Petty MA, Wettstein JG. White matter ischaemia. Brain Res Brain Res Rev 1999; 31: 58-64.
74. Yam PS, Dewar D, McCulloch J. Axonal injury caused by focal cerebral ischemia in the rat. J Neurotrauma 1998; 15: 441-50.
75. Guizar-Sahagún G, García-López P, Espitia AL, Grijalva I, Franco-Bourland RE, Madrazo I. Transitory expression of NADPH diaphorase (NOS) in axonal swellings after spinal cord injury. Neuroreport 1998; 9: 2899-902.
76. Agrawal SK, Nashmi R, Fehlings MG. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience 2000; 99: 179-88.
77. De Keyser J, Sulter G, Luiten PG. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 1999; 22: 535-40.
78. Salter MG, Fern R. NMDA receptors are expressed in developing oligo-dendrocyte processes and mediate injury. Nature 2005; 438: 1167-71.
79. Verkhratsky A, Kirchhoff F. NMDA Receptors in glia. Neuroscientist 2007; 13: 28-37.
80. Bakiri Y, Hamilton NB, Karadottir R, Attwell D. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 2008; 56: 233-40.
81. Stys PK, Lipton SA. White matter NMDA receptors: an unexpected new therapeutic target? Trends Pharmacol Sci 2007; 28: 561-6.
82. Arias-Carrión O, Drucker-Colín R. Neurogénesis como estrategia tera- péutica para regenerar el sistema nervioso central. Rev Neurol 2007; 45: 739-45.
83. Kokovay E, Shen Q, Temple S. The incredible elastic brain: how neural stem cells expand our minds. Neuron 2008; 60: 420-9.